Filed: 8/14/2024ACC: 0001214659-24-014671
📋 What this filing means
CUTTER CAPITAL MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 26 equity positions with a total reported market value of $331.29M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
26
Positions
$331.29M
Total AUM (reported)
10.20M
Total Shares
Allocation by class
COM$212.53M64.2%
SPONSORED ADS$30.02M9.1%
SHS CLASS A$18.26M5.5%
COM PAR $.01$15.25M4.6%
COM NEW$12.84M3.9%
NAMEN AKT$10.88M3.3%
COMMON STOCK$10.32M3.1%
Portfolio Concentration
Top 3$64.36M19.4%
4–10$121.29M36.6%
11–25$143.07M43.2%
Rest$2.57M0.8%
Top 3 weight
19.4%
Top 10 weight
56.0%
Voting Authority Distribution
Total shares with voting rights: 10.20M
Sole
Full voting authority
10.20M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole26
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings26
Rows:
BIOMARIN PHARMACEUTICAL INC
SOLEShares273.53K
TypeSH
Market value$22.52M
6.80%
Sole
273.53K
Shared
0.00
None
0.00
MERCK & CO INC
SOLEShares175.60K
TypeSH
Market value$21.74M
6.56%
Sole
175.60K
Shared
0.00
None
0.00
GILEAD SCIENCES INC
SOLEShares292.96K
TypeSH
Market value$20.10M
6.07%
Sole
292.96K
Shared
0.00
None
0.00
AMGEN INC
SOLEShares64.20K
TypeSH
Market value$20.06M
6.06%
Sole
64.20K
Shared
0.00
None
0.00
ROYALTY PHARMA PLC
SOLEShares692.30K
TypeSH
Market value$18.26M
5.51%
Sole
692.30K
Shared
0.00
None
0.00
BIOGEN INC
SOLEShares76.73K
TypeSH
Market value$17.79M
5.37%
Sole
76.73K
Shared
0.00
None
0.00
KENVUE INC
SOLEShares960.40K
TypeSH
Market value$17.46M
5.27%
Sole
960.40K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares109.38K
TypeSH
Market value$17.28M
5.22%
Sole
109.38K
Shared
0.00
None
0.00
INSMED INC
SOLEShares227.64K
TypeSH
Market value$15.25M
4.60%
Sole
227.64K
Shared
0.00
None
0.00
LEGEND BIOTECH CORP
SOLEShares343.13K
TypeSH
Market value$15.20M
4.59%
Sole
343.13K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares365K
TypeSH
Market value$15.00M
4.53%
Sole
365K
Shared
0.00
None
0.00
TEVA PHARMACEUTICAL INDS LTD
SOLEShares911.90K
TypeSH
Market value$14.82M
4.47%
Sole
911.90K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares236.90K
TypeSH
Market value$12.84M
3.87%
Sole
236.90K
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares1.98M
TypeSH
Market value$12.21M
3.68%
Sole
1.98M
Shared
0.00
None
0.00
CRISPR THERAPEUTICS AG
SOLEShares201.50K
TypeSH
Market value$10.88M
3.29%
Sole
201.50K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares187K
TypeSH
Market value$10.32M
3.12%
Sole
187K
Shared
0.00
None
0.00
AVADEL PHARMACEUTICALS PLC
SOLEShares733K
TypeSH
Market value$10.31M
3.11%
Sole
733K
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS IN
SOLEShares295.77K
TypeSH
Market value$8.92M
2.69%
Sole
295.77K
Shared
0.00
None
0.00
AVANTOR INC
SOLEShares400K
TypeSH
Market value$8.48M
2.56%
Sole
400K
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares230K
TypeSH
Market value$8.32M
2.51%
Sole
230K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares311.70K
TypeSH
Market value$7.90M
2.38%
Sole
311.70K
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares160.17K
TypeSH
Market value$7.63M
2.30%
Sole
160.17K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares222.99K
TypeSH
Market value$5.21M
1.57%
Sole
222.99K
Shared
0.00
None
0.00
PFIZER INC
SOLEShares185.20K
TypeSH
Market value$5.18M
1.56%
Sole
185.20K
Shared
0.00
None
0.00
EVOLUS INC
SOLEShares465.30K
TypeSH
Market value$5.05M
1.52%
Sole
465.30K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 273.53K | SH | $22.52M 6.80% | 273.53K | 0.00 | 0.00 |
MERCK & CO INCSOLE | COM | 175.60K | SH | $21.74M 6.56% | 175.60K | 0.00 | 0.00 |
GILEAD SCIENCES INCSOLE | COM | 292.96K | SH | $20.10M 6.07% | 292.96K | 0.00 | 0.00 |
AMGEN INCSOLE | COM | 64.20K | SH | $20.06M 6.06% | 64.20K | 0.00 | 0.00 |
ROYALTY PHARMA PLCSOLE | SHS CLASS A | 692.30K | SH | $18.26M 5.51% | 692.30K | 0.00 | 0.00 |
BIOGEN INCSOLE | COM | 76.73K | SH | $17.79M 5.37% | 76.73K | 0.00 | 0.00 |
KENVUE INCSOLE | COM | 960.40K | SH | $17.46M 5.27% | 960.40K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 109.38K | SH | $17.28M 5.22% | 109.38K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 227.64K | SH | $15.25M 4.60% | 227.64K | 0.00 | 0.00 |
LEGEND BIOTECH CORPSOLE | SPONSORED ADS | 343.13K | SH | $15.20M 4.59% | 343.13K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 365K | SH | $15.00M 4.53% | 365K | 0.00 | 0.00 |
TEVA PHARMACEUTICAL INDS LTDSOLE | SPONSORED ADS | 911.90K | SH | $14.82M 4.47% | 911.90K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 236.90K | SH | $12.84M 3.87% | 236.90K | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | COM | 1.98M | SH | $12.21M 3.68% | 1.98M | 0.00 | 0.00 |
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 201.50K | SH | $10.88M 3.29% | 201.50K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 187K | SH | $10.32M 3.12% | 187K | 0.00 | 0.00 |
AVADEL PHARMACEUTICALS PLCSOLE | COM SHS | 733K | SH | $10.31M 3.11% | 733K | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 295.77K | SH | $8.92M 2.69% | 295.77K | 0.00 | 0.00 |
AVANTOR INCSOLE | COM | 400K | SH | $8.48M 2.56% | 400K | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 230K | SH | $8.32M 2.51% | 230K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 311.70K | SH | $7.90M 2.38% | 311.70K | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | COM | 160.17K | SH | $7.63M 2.30% | 160.17K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 222.99K | SH | $5.21M 1.57% | 222.99K | 0.00 | 0.00 |
PFIZER INCSOLE | COM | 185.20K | SH | $5.18M 1.56% | 185.20K | 0.00 | 0.00 |
EVOLUS INCSOLE | COM | 465.30K | SH | $5.05M 1.52% | 465.30K | 0.00 | 0.00 |
Page 1 of 2